Abiopharma

🔍 Pate R. Hewitt (Executive)

Company: CHEVRON CORP (CVX)

Report Date: 2026-08-18

Detailed Transactions and Holdings:

• Sold 2,470 shares of Common Stock at $205.1088 per share (Direct)
  Date: 2026-08-18 | Code: S | equity_swap_involved: 0 | shares_owned_after: 10,794.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-18 | Code: H | shares_owned_after: 8,719.00 | Footnotes: F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-18 | Code: H | nature_of_ownership: By 401(k) plan | shares_owned_after: 9,664.00 | Footnotes: F3
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-18 | Code: H | nature_of_ownership: By Pate Family Trust | shares_owned_after: 20.00

Footnotes:

• F1: The reporting person disclaims beneficial ownership of the shares held by his spouse's trust, and this report should not be deemed an admission that the reporting person is the beneficial owner of the shares held by his spouse's trust for purposes of Section 16 or for any other purpose.
• F2: This number includes the acquisition of stock resulting from the reinvestment of dividends on vested stock units (81) issued under the Chevron Corporation 2022 Long-Term Incentive Plan.
• F3: Between March 31, 2026 and August 18, 2026, the reporting person acquired 90 shares of Chevron common stock under the Chevron Employee Savings Investment Plan, a 401(k) plan.